Restructuring Actions (Tables)

9 Months Ended

Sep. 30, 2020

2019 Restructuring Actions

Schedule of restructuring charges by income statement line

(Millions)	Second Quarter 2019
Cost of sales	$	18
Selling, general and administrative expenses		89
Research, development and related expenses		5
Total operating income impact		112
Other expense (income), net		36
Total income before taxes impact	$	148

Components of restructuring by business segment

	Second Quarter 2019
(Millions)	Employee-Related		Asset-Related		Total
Safety and Industrial	$	11	$	—	$	11
Transportation and Electronics		8		—		8
Health Care		6		—		6
Consumer		5		—		5
Corporate and Unallocated		42		40		82
Total Operating Expense	$	72	$	40	$	112

Accrued restructuring action balances

(Millions)	Employee-Related
Accrued restructuring action balances as of December 31, 2019	$	140
Cash Payments		(25)
Adjustments		(55)
Accrued restructuring action balances as of September 30, 2020	$	60

Drug delivery business | 2020 Restructuring Actions

Schedule of restructuring charges by income statement line

(Millions)	Second Quarter 2020
Cost of sales	$	42
Selling, general and administrative expenses		12
Research, development and related expenses		1
Total operating income impact	$	55

Accrued restructuring action balances

(Millions)	Employee-Related		Asset-Related and Other		Total
Expense incurred in the second quarter of 2020	$	32	$	23	$	55
Non-cash changes		—		(14)		(14)
Cash payments		(7)		—		(7)
Accrued divestiture-related restructuring action balances as of September 30, 2020	$	25	$	9	$	34

COVID-19 Pandemic | 2020 Restructuring Actions

Schedule of restructuring charges by income statement line

(Millions)	Second Quarter 2020
Cost of sales	$	13
Selling, general and administrative expenses		37
Research, development and related expenses		8
Total operating income impact	$	58

Components of restructuring by business segment

	Second Quarter 2020
(Millions)	Employee-Related		Asset-Related		Total
Safety and Industrial	$	7	$	—	$	7
Transportation and Electronics		11		—		11
Health Care		12		—		12
Consumer		5		—		5
Corporate and Unallocated		—		23		23
Total Operating Expense	$	35	$	23	$	58

Accrued restructuring action balances

(Millions)	Employee-Related		Asset-Related		Total
Expense incurred in the second quarter of 2020	$	35	$	23	$	58
Non-cash changes		—		(23)		(23)
Adjustments		(9)		—		(9)
Accrued restructuring action balances as of September 30, 2020	$	26	$	—	$	26